Science Explorer Interactive view Map
Company · Vienna · Austria

Takeda (Austria)

Research works
90
▲ 3418% vs 2013–17
Citations
1k
11.2 per fractional work
Top-10% rate
14.0%
record average 16.5%
Open access
78%
world 28%

Not ranked overall: Takeda (Austria) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.21× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.78× its world share, 14 worksBiochemistry, Geneti…Immunology and Microbiology: 5.53× its world share, 3 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 4.70× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 2.54× its world share, 0 worksChemical EngineeringChemistry: 0.84× its world share, 1 worksChemistryComputer Science: 0.14× its world share, 0 worksComputer ScienceEngineering: 0.35× its world share, 2 worksEngineeringEnvironmental Science: 0.09× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.24× its world share, 0 worksMaterials ScienceMathematics: 0.60× its world share, 0 worksMathematicsPhysics and Astronomy: 0.16× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.10× its world share, 0 worksHealth ProfessionsMedicine: 2.54× its world share, 23 worksMedicineNursing: 1.57× its world share, 0 worksNursingEconomics, Econometrics and Finance: 0.11× its world share, 0 worksEconomics, Econometr…world share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.8×. Every wedge is a field page.

Which keywords describe research at Takeda (Austria)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Thrombosis, Gene Therapy, Hemostasis, Inflammation, SARS-CoV-2, Glycosylation, Vaccine and Monoclonal Antibodies.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation5▲ 5.2×11 topics
  2. Thrombosis5▲ 35×6 topics
  3. Gene Therapy4▲ 50×3 topics
  4. Hemostasis4▲ 96×3 topics
  5. Epidemiology4▲ 2.3×11 topics
  6. SARS-CoV-24▲ 28×4 topics
  7. Glycosylation3▲ 65×3 topics
  8. Vaccine3▲ 18×4 topics
  9. Monoclonal Antibodies3▲ 79×3 topics
  10. Angiogenesis3▲ 21×4 topics
  11. Biopharmaceuticals3▲ 122×3 topics
  12. Monoclonal Antibody3▲ 116×2 topics
  13. Immunogenicity3▲ 137×2 topics
  14. Mammalian Cells3▲ 251×1 topic
  15. Recombinant Protein3▲ 251×1 topic
  16. Therapeutic Antibodies3▲ 84×2 topics
  17. Cancer Progression3▲ 31×2 topics
  18. Extracellular Matrix3▲ 32×2 topics
  19. Inhibitors3▲ 138×2 topics
  20. Cell Signaling2▲ 35×3 topics
  21. Prophylaxis2▲ 42×2 topics
  22. Recombinant Proteins2▲ 161×2 topics
  23. Factor VIII2▲ 349×1 topic
  24. Hemophilia2▲ 349×1 topic
  25. Matrix Metalloproteinases2▲ 36×1 topic
  26. Tissue Inhibitors of Metalloproteinases2▲ 331×1 topic
  27. ACE2 Receptor2▲ 19×2 topics
  28. Protein Aggregation2▲ 90×1 topic
  29. Stability2▲ 21×1 topic
  30. Biosensors2▲ 8.3×4 topics
  31. Immune Thrombocytopenic Purpura2▲ 164×1 topic
  32. Pathogenesis2▲ 8.4×4 topics
  33. Platelets2▲ 62×1 topic
  34. AAV2▲ 99×1 topic
  35. Antithrombotic Therapy2▲ 51×2 topics
  36. Immune Response2▲ 7.3×4 topics
  37. Viral Transmission2▲ 27×2 topics
  38. Viral Vectors2▲ 99×1 topic
  39. Protease-Activated Receptors2▲ 198×1 topic
  40. Thrombin2▲ 198×1 topic

Which research topics does Takeda (Austria) publish most on?

By volume in 2022–2025: Viral Infectious Diseases and Gene Expression in Insects, Hemophilia Treatment and Research, Protease and Inhibitor Mechanisms and Protein purification and stability.

  1. 1 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 3 works
  2. 2 Hemophilia Treatment and Research Hematology 2 works
  3. 3 Protease and Inhibitor Mechanisms Cancer Research 2 works
  4. 4 Protein purification and stability Molecular Biology 2 works
  5. 5 Platelet Disorders and Treatments Hematology 2 works
  6. 6 Virus-based gene therapy research Genetics 2 works
  7. 7 Blood Coagulation and Thrombosis Mechanisms Hematology 2 works
  8. 8 SARS-CoV-2 detection and testing Infectious Diseases 2 works
  9. 9 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
  10. 10 Viral gastroenteritis research and epidemiology Infectious Diseases 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available78.4%not open21.6%

World: 28% of research is openly available.

with international co-authors34.0%domestic only66.0%

World: 19% is written across borders.

How has Takeda (Austria)'s research output changed?

Output in 2018–2022 was 3418% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Vienna

All research institutions in Vienna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.